Skip to main content
Ventripoint Diagnostics Ltd. logo

Ventripoint Diagnostics Ltd. — Investor Relations & Filings

Ticker · VPT ISIN · CA92281P2008 LEI · 529900QV0P93LL6P2M57 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 689 across all filing types
Latest filing 2026-05-19 Share Issue/Capital Cha…
Country CA Canada
Listing TSXV VPT

About Ventripoint Diagnostics Ltd.

https://ventripoint.com/

Ventripoint Diagnostics Ltd. is a medical device company specializing in AI-driven cardiac imaging solutions. The company's patented technology, embodied in the VMS+ software, transforms standard 2D echocardiograms into high-fidelity 3D models of all four heart chambers. This process provides accurate, reproducible volumetric measurements and ejection fractions, offering diagnostic performance comparable to MRI but with the speed and cost-effectiveness of ultrasound. The VMS+ system is designed to aid in monitoring patients with heart conditions, delivering detailed heart analysis even when using imperfect images or on patients who cannot undergo MRI procedures, such as those with pacemakers.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Share Issue/Capital Change Classification · 85% confidence The document is a Canadian Form 51-102F3 Material Change Report disclosing that the company has issued common shares to pay debenture interest. This constitutes an announcement of a new share issuance and related capital change. Among our filing categories, ‘Share Issue/Capital Change’ (SHA) specifically covers announcements of new share issues or capital structure changes. Thus the correct classification is SHA.
2026-05-19 English
News release - English.pdf
Share Issue/Capital Change Classification · 87% confidence The document is a press release announcing that the company will issue new common shares to pay debenture interest. This is an announcement of a share issuance/capital change rather than an earnings release, board change, or regulatory filing. It does not contain full financial statements or an attached report, and it clearly describes the issuance of shares for payment of interest on convertible debentures. Therefore, it falls under Share Issue/Capital Change (Code: SHA).
2026-05-19 English
News release - English.pdf
Regulatory Filings
2026-05-04 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2026-05-01 English
Annual MD&A - English.pdf
Regulatory Filings
2026-05-01 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2026-05-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.